Publications by authors named "D Meisel"

Using a panel study design, we aimed to estimate the seroconversion and seroreversion rates of anti-Strongyloides IgG antibodies from surveys carried out 11 months apart in a rural community in the Amazon Basin in Brazil. We used enzyme immunoassays to measure anti-Strongyloides IgG antibodies in 325 baseline plasma samples and 224 others that were collected 11 months later from residents in the agricultural settlement of Granada, Acre State. We observed anti-Strongyloides IgG antibodies in 21.

View Article and Find Full Text PDF
Article Synopsis
  • Immunosuppressed patients, especially those who have undergone organ transplants, are at risk for severe infections from the parasite Strongyloides stercoralis.
  • This study focused on detecting anti-Strongyloides IgG antibodies in liver transplant patients using two methods: an initial screening with ELISA and confirmation with Western blotting.
  • The results showed a 10.9% reactivity rate in the ELISA test, with a significant portion of positive cases identifying a specific protein fraction, emphasizing the need for routine screening for this infection in liver transplant recipients.
View Article and Find Full Text PDF

Strongyloidiasis has been a neglected parasitic infection caused by Strongyloides genus parasites. Despite assessment of S. stercoralis exposure in different vulnerable populations, seroprevalence in inmates worldwide remains to be fully established.

View Article and Find Full Text PDF

Strongyloides stercoralis, a pathogenic roundworm, is considered endemic in several tropical and subtropical areas worldwide. Indigenous populations have the highest soil-transmitted helminthiases-related mortality rates, but the prevalence and risk factors associated with S. stercoralis in Brazilian indigenous populations have not been established.

View Article and Find Full Text PDF

Background: HPV vaccination has been recommended and reimbursed for girls in Germany since 2007. In June 2018 the German Standing Committee on Vaccination (STIKO) recommended the gender-neutral vaccination of adolescents aged 9 to 14 years with catch-up through age 17. Objectives of this study were to describe the uptake of vaccination in boys before and during the COVID-19 pandemic.

View Article and Find Full Text PDF